Hyderabad-based Helex Inc is working on a first-in-class mechanism to deliver gene editing drugs safely into the kidneys—a massive medical challenge currently. They not only want to do it first, but ...

A plan to give Americans easier access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. was ...

Results of a phase 1/2 trial led by Roswell Park Comprehensive Cancer Center show that combining the targeted therapies bevacizumab (Avastin) and pazopanib (Votrient) significantly extends both ...

Vantive announced a $100 million expansion of its Mountain Home facility, expected to create 175 jobs over four years and ...

FAB-KLEAR investigates lucerastat as a potential disease-modifying therapy targeting the kidney manifestations of Fabry ...

Joubert syndrome demonstrates how genetics, environmental influences, nutrition and medical care interact to shape health ...

Former Ohio State Buckeye Terence Dials was in need of a kidney transplant. His former teammate, J.J. Sullinger, answered the ...

The prespecified interim analysis of NEOTORCH in patients with resectable stage III NSCLC previously demonstrated statistically significant improvements in EFS and MPR. The results were presented t ...

These data were supported by studies in minipigs, a well-validated translational model in renal research, demonstrating a surrogate PS-003 vector delivered full-length COL4A5 gene to the kidney with ...

Active LN patients in the Phase 1 study treated with FT819 and the less-intensive conditioning (bendamustine) regimen selected for the RECLAIM-LN ...

Real-world analysis showed serum phosphate reductions following XPHOZAH initiation across all phosphate binder groups ...